Detalhe da pesquisa
1.
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
Hematol Oncol
; 38(4): 478-486, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32542788
2.
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
Br J Haematol
; 166(1): 69-76, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24673512
3.
Interesting activity of pegylated liposomal doxorubicin in primary refractory and multirelapsed Hodgkin lymphoma patients: bridge to transplant.
Hematol Oncol
; 36(2): 489-491, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363146
4.
Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma.
Hematol Oncol
; 34(1): 49-51, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25243375
5.
Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma.
Int Rev Immunol
; 38(2): 79-91, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30931651
6.
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
Leuk Lymphoma
; 47(10): 2096-101, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17071482